Los Angeles Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Los Angeles Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-69,368	Closed	-$8.03M	–	1277
2023 Q3	$8.03M	Sell	69,368 -13,928	-17%	-$1.5M	0.03%	263
2023 Q2	$8.57M	Sell	83,296 -66,023	-44%	-$6.97M	0.03%	276
2023 Q1	$16.3M	Buy	149,319 +3,507	+2%	+$388K	0.07%	223
2022 Q4	$16.6M	Sell	145,812 -9,304	-6%	-$773K	0.08%	205
2022 Q3	$9.6M	Buy	+155,116	New	+$10.8M	0.05%	279
2021 Q4	–	Sell	-1,929	Closed	-$211K	–	1556
2021 Q3	$211K	Buy	+1,929	New	+$200K	﹤0.01%	1415
2021 Q2	–	Sell	-5,466	Closed	-$503K	–	1750
2021 Q1	$503K	Sell	5,466 -76,604	-93%	-$6.46M	﹤0.01%	1216
2020 Q4	$6M	Buy	82,070 +13,319	+19%	+$990K	0.03%	368
2020 Q3	$5.34M	Buy	68,751 +17,569	+34%	+$1.21M	0.02%	352
2020 Q2	$2.85M	Buy	51,182 +32,454	+173%	+$1.39M	0.01%	521
2020 Q1	$555K	Buy	18,728 +5,205	+38%	+$176K	﹤0.01%	877
2019 Q4	$490K	Sell	13,523 -20,435	-60%	-$627K	﹤0.01%	1021
2019 Q3	$925K	Sell	33,958 -30,067	-47%	-$777K	0.01%	824
2019 Q2	$1.54M	Sell	64,025 -2,400	-4%	-$60.9K	0.01%	711
2019 Q1	$1.76M	Buy	+66,425	New	+$1.57M	0.01%	690
2018 Q4	–	Sell	-28,335	Closed	-$555K	–	1459
2018 Q3	$555K	Buy	+28,335	New	+$539K	﹤0.01%	1074
2018 Q2	–	Sell	-17,580	Closed	-$250K	–	1525
2018 Q1	$250K	Buy	+17,580	New	+$260K	﹤0.01%	1214
2017 Q4	–	Sell	-101,395	Closed	-$1.29M	–	1443
2017 Q3	$1.29M	Buy	101,395 +57,360	+130%	+$729K	0.01%	739
2017 Q2	$523K	Buy	+44,035	New	+$548K	﹤0.01%	928

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Los Angeles Capital Management's HZNP Position: Q4 2023 in Review

Los Angeles Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 69,368 shares — an estimated $8.03M sold.

Los Angeles Capital Management first reported a position in HZNP in Q2 2017 and held it in 19 quarters. The position peaked at $16.6M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Los Angeles Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Los Angeles Capital Management sold 69,368 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $8.03M.
Los Angeles Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 19 quarters.
Los Angeles Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $16.6M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Los Angeles Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.